Web Results

Becaplermin

en.wikipedia.org/wiki/Becaplermin

Becaplermin (brand name Regranex) is a cicatrizant, available as a topical gel. Regranex is a human platelet-derived growth factor indicated along with good ...

Regranex (Becaplermin): Side Effects, Interactions, Warning ... - RxList

www.rxlist.com/regranex-drug.htm

Learn about Regranex (Becaplermin) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.

REGRANEX Gel for Treatment of Diabetic Foot Ulcers

www.regranex.com/

Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients ...

becaplermin, Regranex: Drug Facts, Side Effects and Dosing

www.medicinenet.com/becaplermin/article.htm

Nov 17, 2014 ... Becaplermin (Regranex) is a drug prescribed to people with diabetes to help heal diabetic ulcers of the lower limbs. Some serious side effects ...

Regranex Gel (becaplermin) dosing, indications, interactions ...

reference.medscape.com/drug/regranex-gel-becaplermin-topical-343538

Medscape - Indication-specific dosing for Regranex Gel (becaplermin), frequency -based adverse effects, comprehensive interactions, contraindications, ...

Becaplermin: Indications, Side Effects, Warnings - Drugs.com

www.drugs.com/cdi/becaplermin.html

Easy to read patient leaflet for becaplermin. Includes indications, proper use, special instructions, precautions, and possible side effects.

A review of becaplermin gel in the treatment of diabetic neuropathic ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC2727777/

This review examines the scientific underpinnings supporting the use of becaplermin (Regranex<sup>®</sup>; Ortho-McNeil Pharmaceutical, Raritan, NJ), or recombinant ...

Therapeutic Biologic Applications (BLA) > Becaplermin Product ...

www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/ucm080740.htm

Oct 9, 2015 ... Becaplermin Product Approval Information - Licensing Action. Share · Tweet · Linkedin · Pin it; More sharing options. Linkedin · Pin it.

Regranex Label - FDA

www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM142821.pdf

Gel contains becaplermin, a recombinant human platelet-derived ... applications of becaplermin gel 0.01% at a dose range of 0.32-2.95 µg/kg (7µg/cm. 2. ).

(becaplermin) Information - FDA

www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm196778.htm

Jul 10, 2015 ... Regranex (becaplermin) Information ... Communication about an Ongoing Safety Review of Regranex (becaplermin) [ARCHIVED] 3/27/2008 ...

More Info

Becaplermin Topical: MedlinePlus Drug Information

medlineplus.gov

At this time, there is not enough information to tell if people who use becaplermin gel are more likely to develop cancer than people who do not use the ...

DrugBank: Becaplermin

www.drugbank.ca

Becaplermin is produced by recombinant DNA technology by insertion of the gene for the B chain of platelet derived growth factor (PDGF) into the yeast, ...

Becaplermin: recombinant platelet derived growth factor, a new - NCBI

www.ncbi.nlm.nih.gov

Expert Opin Biol Ther. 2002 Feb;2(2):211-8. Becaplermin: recombinant platelet derived growth factor, a new treatment for healing diabetic foot ulcers.